Aging and dementia : Clinical relevance of early markers and late interventions


Dateien zu dieser Ressource

Prüfsumme: MD5:ab1c722cdb23eac886aedbbff4fed20c

THURM, Franka, 2012. Aging and dementia : Clinical relevance of early markers and late interventions

@phdthesis{Thurm2012Aging-19716, title={Aging and dementia : Clinical relevance of early markers and late interventions}, year={2012}, author={Thurm, Franka}, note={Projekt: Neuroplastizität und Immunologie bei kognitiver Beeinträchtigung im Alter (gefördert von der Heidelberger Akademie der Wissenschaften, Leitung: Prof. Dr. Iris-Tatjana Kolassa)}, address={Konstanz}, school={Universität Konstanz} }

Altern und Demenz : Klinische Relevanz von frühen Markern und späten Interventionen Aging and dementia : Clinical relevance of early markers and late interventions eng Thurm, Franka 2012-07-10T06:28:14Z Thurm, Franka The human life expectancy is steadily rising worldwide. Currently, the maximum life span is 122 years. This remarkably old age was reached by Jeanne Calment. She was born on 21 February 1875 in France and died on 4 August 1997. She became 122 years and 164 days old and was cognitively fit throughout. According to the Gerontology Research Group (, altogether 70 so-called supercentenarians (among those 65 women) aged 110-115 years exist at present (last updated on 4 April 2012). Supercentenarians seem to evade or at least postpone the negative influence of age-associated morbidity including as vascular diseases and diabetes (Schoenhofen et al., 2006). More than 80% of the over-90-year-olds live independently (Perls, 2002). What is their secret? A healthy lifestyle concerning diet, physical exercise and health behavior is associated with up to ten years longer life expectancies (Fraser & Shavlik, 2001). Genetics play a moderate role, having a 20-30% influence on survival (e.g., Herskind et al., 1996; Perls, 2002). Longevity (i.e., > 90 years of age) reoccurs more often in siblings who have at least one very old family member (e.g., Perls et al., 2007). However, exceptional longevity (i.e., > 110 years of age) is still very rare. It is further unclear how genetic and environmental factors contribute to healthy survival beyond the 11th decade (Leslie, 2008; Sebastiani et al., 2012).<br />In Germany, 200,000 older adults develop Alzheimer’s disease (AD) per year. After the diagnosis it takes approximately seven years until death. However, the pathological, neuronal changes already start decades before Alzheimer-associated memory and behavioral problems become obvious ( Hence, the main goals of aging and dementia research focus on the detection of possible biomarkers to allow early diagnosis of pathological cognitive decline and AD as well as on the development of efficient intervention approaches for patients already affected by dementia.<br />For this thesis, four studies have been carried out to investigate potential biomarker candidates for AD and a late intervention approach for dementia patients with comorbid physical restraints. Study 1 focused on the establishment of a new ELISA (enzyme-linked immunosorbent assay) method for the determination of physiological, naturally occurring beta-Amyloid autoantibody complexes (Aβ-IgG immune complexes) in serum of 47 healthy adults aged 18-89 years. Results showed no association of the Aβ-IgG immune complexes with age or cognitive test scores of the participants, indicating that healthy aging is not necessarily associated with an altered production of Aβ-autoantibodies or with a decreased Aβ cleaving in the periphery.<br /><br />In study 2, this new ELISA method was also applied for the determination of Aβ-IgG immune complexes in serum and cerebrospinal fluid (CSF) of 58 Alzheimer patients compared to 54 non-demented control subjects. AD patients showed significantly higher levels of Aβ-IgG immune complexes in serum and CSF than controls. Sensitivity and specificity were not sufficient for the application as a self-standing biomarker of AD in clinical routine. However, Aβ-IgG immune complexes in serum, which can be obtained minimally invasive, could provide supplemental information for early diagnosis of AD and for therapy monitoring in the future.<br /><br />Study 3 investigated the error-related negativity (ERN) and the correct-related negativity (CRN) by means of electroencephalography (EEG) in 14 older adults with mild cognitive impairment (MCI), 16 younger and 16 older adult control subjects. MCI refers to a gray zone between healthy and pathological aging or AD. Results showed a significant alteration in MCI patients compared to both control groups. In contrast, healthy older adult controls showed no difference compared to the younger adult control subjects. Event-related potentials (ERPs) could therefore provide additional information for early diagnosis of MCI and AD, although the biomarker criteria are not yet fulfilled.<br /><br />Finally, study 4 investigated the efficiency of a multimodal physical training in a small sample of institutionalized and physically very frail nursing home residents with dementia. Cognitive performance of the training group stabilized and partially improved after ten weeks of training compared to control subjects who showed further cognitive deterioration. This result indicates that physical training is applicable and effective even in cases with progressing dementia and physical restraints. 2012-07-10T06:28:14Z 2012 deposit-license

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Dissertation_Thurm_2012.pdf 249

Das Dokument erscheint in:

KOPS Suche


Mein Benutzerkonto